Initial treatment with lansoprazole in young dyspeptic patients with negative urea breath test result: A randomized controlled trial with 12-month follow-up

American Journal of Gastroenterology

Volumn 102, Issue 7, 2007, Pages 1483-1488

  Leung, Wai K ^a   Wu, Justin C Y ^a   Chan, Francis K L ^a   Fung, Sara S L ^a   Wong, Vincent W S ^a   Hui, Aric J ^a   Hung, Lawrence C T ^a   Sung, Joseph J Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

LANSOPRAZOLE; PLACEBO;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG TREATMENT FAILURE; DYSPEPSIA; FEMALE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HEALTH CARE UTILIZATION; HEALTH SERVICE; HELICOBACTER PYLORI; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT MONITORING; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; STATISTICAL ANALYSIS; SYMPTOM; TREATMENT DURATION; TREATMENT RESPONSE; UREA BREATH TEST;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADOLESCENT; ADULT; AGE FACTORS; CARBON ISOTOPES; DIAGNOSIS, DIFFERENTIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DYSPEPSIA; ENDOSCOPY, GASTROINTESTINAL; ENZYME INHIBITORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROTON PUMPS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; UREA;

EID: 34250808021     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01229.x     Document Type: Article

References (18)

1. Jones RH, Lydeard SE, Hobbs FD, et al. Dyspepsia in England and Scotland. Gut 1990 31 : 401 5.
2. Talley NJ, Zinsmeister AR, Schleck CD, et al. Dyspepsia and dyspepsia subgroups: A population-based study. Gastroenterology 1992 102 : 1259 68.
3. McCormick A, Fleming D, Charlton J. Morbidity statistics from general practice: Fourth national study 1991-1992, Vol MB5 no. 3. London : Office of Population Censuses and Surveys, 1995.
4. Statistics of prescription dispensed in the Family Health Services Authorities. England 1984-94. Statistical bulletin, Vol 9515. London : HMSO, 1995.
5. Delany B, Ford AC, Forman D, et al. Initial management strategies for dyspepsia. Cochrane Database Syst Rev 2005 4 : CD001961.
6. Talley NJ, Vakil N, and the Practice Parameters Committee of the American College of Gastroenterology. Guidelines for the management of dyspepsia. Am J Gastroenterol 2005 100 : 2324 37.
7. Moayyedi P, Delaney BC, Vakil N, et al. The efficacy of proton pump inhibitors in nonulcer dyspepsia: A systematic review and economic analysis. Gastroenterology 2004 127 : 1329 37.
8. Drossman DA, Corrazziari E, Talley NJ, et al. Rome II: The functional gastrointestinal disorders, 2nd Ed. McLean, VA : Degnon, 2000.
9. Wong WM, Lam SK, Lai KC, et al. A rapid-release 50-mg tablet-based 13C-urea breath test for the diagnosis of Helicobacter pylori infection. Aliment Pharmacol Ther 2003 17 : 253 7.
10. Talley NJ, Janssens J, Lauritsen K, et al. Eradication of Helicobacter pylori in functional dyspepsia: Randomised double blind placebo controlled trial with 12 months' follow-up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) study group. BMJ 1999 318 : 833 7.
11. Rabeneck L, Cook KF, Wristers K, et al. SODA (severity of dyspepsia assessment): A new effective outcome measure for dyspepsia-related health. J Clin Epidemiol 2001 54 : 755 65.
12. Lam CL, Gandek B, Ren XS, et al. Tests of scaling assumptions and construct validity of the Chinese (HK) version of the SF-36 Health Survey. J Clin Epidemiol 1998 51 : 1139 47.
13. Lam CL, Tse EY, Gandek B, et al. The SF-36 summary scales were valid, reliable, and equivalent in a Chinese population. J Clin Epidemiol 2005 58 : 815 22.
14. Rabeneck L, Souchek J, Wristers K, et al. A double blind, randomized, placebo-controlled trial of proton pump inhibitor therapy in patients with uninvestigated dyspepsia. Am J Gastroenterol 2002 97 : 3045 51.
15. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002 16 : 167 80.
16. Peura DA, Kovacs TO, Metz DC, et al. Lansoprazole in the treatment of functional dyspepsia: Two double-blind, randomized, placebo-controlled trials. Am J Med 2004 116 : 740 8.
17. Wong WM, Wong BC, Hung WK, et al. Double blind, randomized, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients. Gut 2002 51 : 502 6.
18. Sung JJ, Lao WC, Lai MS, et al. Incidence of gastro-esophageal malignancy in patients with dyspepsia in Hong Kong: Implications for screening strategies. Gastrointest Endosc 2001 54 : 454 8.